[Iatrogenic pathology in hematology].
D000380:Agranulocytosis / Q000139:chemically induced; D000477:Alkylating Agents / Q000009:adverse effects*; D000741:Anemia, Aplastic / Q000139:chemically induced; D000743:Anemia, Hemolytic / Q000139:chemically induced; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000963:Antimetabolites / Q000009:adverse effects*; D013956:Antithyroid Agents / Q000009:adverse effects; D001778:Blood Coagulation Disorders / Q000139:chemically induced; D001791:Blood Platelet Disorders / Q000139:chemically induced; D004247:DNA / Q000096:biosynthesis; D004342:Drug Hypersensitivity / Q000209:etiology; D005342:Fibrinolysis; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000139:chemically induced; D006402:Hematologic Diseases / Q000139:chemically induced*; D006461:Hemolysis; D006487:Hemostasis; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects; D010630:Phenindione / Q000378:metabolism; D011696:Purpura, Thrombocytopenic / Q000139:chemically induced; D014149:Tranquilizing Agents / Q000009:adverse effects*
D000477:Alkylating Agents; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000963:Antimetabolites; D013956:Antithyroid Agents; D007004:Hypoglycemic Agents; D014149:Tranquilizing Agents; D010630:Phenindione; D004247:DNA
La pathologie iatrogène en hématologie.